Mike has 20 years’ experience of life sciences business development, commercialisation, project management and government relations. He has worked in both the public and private sectors, focusing on the diagnostics industry for the past 10 years. As Commercial Director, Mike is responsible for driving adoption of Oncimmune’s early cancer detection tests in the UK and Europe, building Oncimmune’s activities in companion diagnostics and commercial planning for the company’s next generation of products. Mike Joined Oncimmune from Abcodia, where he was Director of Strategic Alliances and responsible for collaborative early disease detection biomarker validation projects. Prior to this he was Business Development Director for Bio Nano Consulting, a problem solving biotech joint venture between Imperial College and University College. Between 2005 and 2008, Mike was the UK government’s Life Sciences Industry Advisor for North America, based in Cambridge MA, where he liaised between US corporates and the Department of Health, NICE and MHRA. Before working in the US, Mike held project management and economic development roles for both public bodies and consultancies. He was a founder of the Northwest Genetics Knowledge Park and has lead numerous successful grant funded projects from the European Commission and UK government.
3:00 PM - 4:00 PM
Wednesday, June 5
Climbing Cancer’s North Face: The Challenges of Developing and Clinically Validating Biomarkers for Early Cancer Detection
It is widely accepted that early cancer detection improves treatment options and increases 5-year…